Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma

Kalle E. Mattila; Pia Vihinen; Susan Ramadan; Tanja Skyttä; Leena Tiainen; Meri-Sisko Vuoristo; Kristiina Tyynelä-Korhonen; Jussi Koivunen; Laura Kohtamäki; S Mäkelä; Siru Makela; Micaela Hernberg

doi:10.1080/0284186x.2019.1670862

Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma

Kalle E. Mattila, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, S Mäkelä, Siru Makela, Micaela Hernberg

Research output: Contribution to journal › Article › Scientific

3 Citations (Scopus)

Original language	English
Pages (from-to)	310-314
Journal	Acta Oncologica
Volume	59
Issue number	3
DOIs	https://doi.org/10.1080/0284186x.2019.1670862
Publication status	Published - 2019
Publication type	B1 Journal article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/0284186x.2019.1670862

https://pubmed.ncbi.nlm.nih.gov/31564175

Cite this

Mattila, K. E., Vihinen, P., Ramadan, S., Skyttä, T., Tiainen, L., Vuoristo, M-S., Tyynelä-Korhonen, K., Koivunen, J., Kohtamäki, L., Mäkelä, S., Makela, S., & Hernberg, M. (2019). Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma. Acta Oncologica, 59(3), 310-314. https://doi.org/10.1080/0284186x.2019.1670862

@article{8df761ba580f4d6abda0d52c9ec4f4b4,

title = "Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma",

author = "Mattila, {Kalle E.} and Pia Vihinen and Susan Ramadan and Tanja Skytt{\"a} and Leena Tiainen and Meri-Sisko Vuoristo and Kristiina Tyynel{\"a}-Korhonen and Jussi Koivunen and Laura Kohtam{\"a}ki and S M{\"a}kel{\"a} and Siru Makela and Micaela Hernberg",

year = "2019",

doi = "10.1080/0284186x.2019.1670862",

language = "English",

volume = "59",

pages = "310--314",

journal = "Acta Oncologica",

issn = "0284-186X",

number = "3",

}

Mattila, KE, Vihinen, P, Ramadan, S, Skyttä, T, Tiainen, L, Vuoristo, M-S, Tyynelä-Korhonen, K, Koivunen, J, Kohtamäki, L, Mäkelä, S, Makela, S & Hernberg, M 2019, 'Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma', Acta Oncologica, vol. 59, no. 3, pp. 310-314. https://doi.org/10.1080/0284186x.2019.1670862

TY - JOUR

T1 - Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma

AU - Mattila, Kalle E.

AU - Vihinen, Pia

AU - Ramadan, Susan

AU - Skyttä, Tanja

AU - Tiainen, Leena

AU - Vuoristo, Meri-Sisko

AU - Tyynelä-Korhonen, Kristiina

AU - Koivunen, Jussi

AU - Kohtamäki, Laura

AU - Mäkelä, S

AU - Makela, Siru

AU - Hernberg, Micaela

PY - 2019

Y1 - 2019

U2 - 10.1080/0284186x.2019.1670862

DO - 10.1080/0284186x.2019.1670862

M3 - Article

VL - 59

SP - 310

EP - 314

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 3

ER -